We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03502330
Recruitment Status : Active, not recruiting
First Posted : April 18, 2018
Last Update Posted : July 26, 2022
Sponsor:
Collaborators:
Bristol-Myers Squibb
Apexigen, Inc.
Information provided by (Responsible Party):
Yale University